SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH L impact

AZT: Recurring, high-margin enzyme sales drive scalable growth across diversified biotech markets

A high-margin enzyme platform supports advanced therapies and diagnostics, generating recurring revenue and scaling margins. Diversified across four high-growth markets, the business leverages a largely fixed cost base for strong operating leverage and compounding earnings, with multiple growth lev…

AZT

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.

Related stories